|
Synonyms: CVT-303 | Ranexa® | RS-43285 | RS-43285-003
ranolazine is an approved drug (FDA (2006), EMA (2008))
Compound class:
Synthetic organic
Comment: The mechanism of action of ranolazine is largely unknown, but may have some antianginal effects by inhibition of the late sodium current in cardiac cells.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| We have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target. |